Inspire Investing’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Inspire Investing’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,374	Closed	-$230K	–	701
2020 Q3	$230K	Buy	+4,374	New	+$181K	0.06%	307
2020 Q2	–	Sell	-7,949	Closed	-$216K	–	789
2020 Q1	$216K	Buy	+7,949	New	+$221K	0.09%	375
2019 Q4	–	Sell	-14,058	Closed	-$182K	–	376
2019 Q3	$182K	Buy	14,058 +278	+2%	+$3.36K	0.07%	336
2019 Q2	$172K	Buy	13,780 +2,020	+17%	+$26.8K	0.07%	298
2019 Q1	$171K	Buy	+11,760	New	+$150K	0.08%	244

Inspire Investing's MNTA Position: Q4 2020 in Review

Inspire Investing sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 4,374 shares — an estimated $230K sold.

Inspire Investing first reported a position in MNTA in Q1 2019 and held it in 5 quarters. The position peaked at $230K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Inspire Investing reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Inspire Investing sold 4,374 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $230K.
Inspire Investing first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2019 and held it in 5 quarters.
Inspire Investing's Momenta Pharmaceuticals, Inc. position peaked at $230K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Inspire Investing's 13F filing for Q4 2020, filed 12 Feb 2021.